"10.1371_journal.pone.0099070","plos one","2014-06-09T00:00:00Z","Parag R Gajendragadkar; Annette Hubsch; Kaisa M Mäki-Petäjä; Martin Serg; Ian B Wilkinson; Joseph Cheriyan","Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom; Department of Cardiology, University of Tartu, Tartu, Estonia; Cambridge Clinical Trials Unit, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom; Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom","Conceived and designed the experiments: JC IBW. Performed the experiments: PRG AH KMM MS IBW JC. Analyzed the data: PRG AH MS KMM JC. Contributed reagents/materials/analysis tools: PRG AH KMM MS IBW JC. Wrote the paper: PRG AH KMM MS IBW JC.","The authors declare the following: Cambridge Theranostics donated drugs and placebo to the study. Ateronon, a food supplement, is a registered trademark of CamNutra. The authors acknowledge unrestricted educational donations made by Cambridge Theranostics and CamNutra to Addenbrookes Charitable Trust. The donations were unrelated to the trial, which was not funded by either company. The commercial companies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","06","Parag R Gajendragadkar","PRG",6,TRUE,2,6,5,6,TRUE,TRUE,FALSE,0,NA,FALSE
